All journal publications

Found 7 results. Export: Tagged | XML
Filters: author is Lowik  [Clear All Filters]
2015
Rahimian, S., Kleinovink, J.W., Fransen, M.F., Mezzanotte, L., Gold, H., Wisse, P., Overkleeft, H., Amidi, M., Jiskoot, W., Lowik, C.W., Ossendorp, F., Hennink, W.E. , Near-infrared labeled, ovalbumin loaded polymeric nanoparticles based on a hydrophilic polyester as model vaccine: In vivo tracking and evaluation of antigen-specific CD8 T cell immune response, Biomaterials, vol. 37C, pp. 469-477. DOI
Rosalia, R.A., Cruz, L.J., van Duikeren, S., Tromp, A.T., Silva, A.L., Jiskoot, W., de Gruijl, T., Lowik, C., Oostendorp, J., van der Burg, S.H., Ossendorp, F. , CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses, Biomaterials, vol. 40, pp. 88-97. DOI
Kraan, H., Ploemen, I, van de Wijdeven, G., Que, I, Lowik, C., Kersten, G., Amorij, J.P. , Alternative delivery of a thermostable inactivated polio vaccine, Vaccine, vol. 33, no. 17, pp. 2030-7. DOI
2014
Filipe, V., Que, I, Carpenter, J.F., Lowik, C., Jiskoot, W. , In vivo fluorescence imaging of IgG1 aggregates after subcutaneous and intravenous injection in mice, Pharmaceutical research, vol. 31, no. 1, pp. 216-27. DOI
2010
Slutter, B., Bal, S.M., Que, I, Kaijzel, E., Lowik, C., Bouwstra, J., Jiskoot, W. , Antigen-Adjuvant Nanoconjugates for Nasal Vaccination: An Improvement over the Use of Nanoparticles?, Mol Pharm, vol. 7, issue 6, pp. 2207-2215. DOI
Hagenaars, N., Mania, M., de Jong, P., Que, I, Nieuwland, R., Slutter, B., Glansbeek, H., Heldens, J., van den Bosch, H., Lowik, C., Kaijzel, E., Mastrobattista, E., Jiskoot, W. , Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine, J Control Release, vol. 144, no. 1, pp. 17-24. DOI
Slutter, B., Bal, S., Keijzer, C., Mallants, R., Hagenaars, N., Que, I, Kaijzel, E., van Eden, W., Augustijns, P., Lowik, C., Bouwstra, J., Broere, F., Jiskoot, W. , Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen, Vaccine, vol. 28, no. 38, pp. 6282-91. DOI